vadimezan has been researched along with Mesothelioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cornwall, SMJ; Graham, PT; Larma, I; Nelson, DJ; Nowak, AK | 1 |
| Albelda, SM; Cheng, G; Ching, LM; Fridlender, ZG; Sun, J; Wang, LC | 1 |
| Albelda, SM; Burdick, MD; Cheung, L; Ching, LM; Jassar, AS; Kaiser, LR; Kapoor, V; Silverberg, MB; Strieter, RM; Sun, J; Suzuki, E | 1 |
3 other study(ies) available for vadimezan and Mesothelioma
| Article | Year |
|---|---|
The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model.
Topics: Animals; Antigen Presentation; Antigens, Neoplasm; Disease Models, Animal; Mesothelioma; Mesothelioma, Malignant; Mice; Ovalbumin; T-Lymphocytes, Cytotoxic | 2022 |
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
Topics: Antineoplastic Agents; Cells, Cultured; Chemokine CXCL10; Enzyme Inhibitors; Humans; Imidazoles; Immunoblotting; Kidney; Luciferases; Mesothelioma; NF-kappa B; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Nucleotides; Pyridines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Xanthones | 2010 |
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokines; Cytokines; Disease Models, Animal; Immunotherapy; Lung Neoplasms; Macrophages; Membrane Glycoproteins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neovascularization, Pathologic; Perforin; Pore Forming Cytotoxic Proteins; Xanthones | 2005 |